HealthDay - TUESDAY, Sept. 27 (HealthDay News) -- A number of recurrent genetic errors common to advanced lethal prostate cancers have been identified by scientists who conducted the first complete genome mapping of these types of cancers.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.